Example: confidence
PIC/S加盟後のGMP査察と 企業への期待 - nihs.go.jp
pic/s加盟後のgmp査察と 企業への期待 （独)医薬品医機器総合機構 品質管部森末政 平成27年2月9日 医薬品品質フォーラム
Information
Domain:
Source:
Link to this page:
Documents from same domain
NIHS 医薬品安全性情報 Vol.16 No.012018/0111/
www.nihs.go.jpCarafate’]の製品表示が改訂され， 販売名が[‘Carafate suspension’]から [‘Carafate oral suspension’]に変更さ
Guideline for the Development of Liposome Drug …
www.nihs.go.jp4 described in this document are also subject to other relevant notifications and guidelines. The active substances mentioned here include a low-molecular-weight chemical entity, a
Guideline for Bioequivalence Studies of Generic …
www.nihs.go.jp1 Guideline for Bioequivalence Studies of Generic Products for Topical Use July 7, 2003 局所皮膚適用製剤の後発医薬品のための 生物学的同等性試験ガイドライン
Since 1874 遺伝子治療用製品の開発における 国内 …
www.nihs.go.jp遺伝子治療の現状 海外の遺伝子治療の規制と国際調和 日本の遺伝子治療と関連規制 遺伝子治療指針の改正
Guideline for Bioequivalence Studies for Different ...
www.nihs.go.jp2 Section 1: Introduction This guideline describes the principles of procedures of bioequivalence studies for oral solid dosage forms that contains a different quantity of the active ingredient from an
Clinical Pharmacokinetic Studies of Pharmaceuticals
www.nihs.go.jp- 1 - Clinical Pharmacokinetic Studies of Pharmaceuticals This document is an informal translation of the official text that was promulgated in Japanese on
平成 25 年度報告 毒物劇物指定の ... - nihs.go.jp
www.nihs.go.jp平成. 25 年度報告 毒物劇物指定のための有害性情報の収集・評価. 物質名： n-(2-
毒物及び劇物取締法Q＆A - nihs.go.jp
www.nihs.go.jp1 平成29年3月31日更新 毒物及び劇物取締法Q＆A 質問一覧 1．毒物及び劇物取締法について ..... 4
European Medicines Agency - NIHS
www.nihs.go.jpWhat is Quality Risk Management? • Proposed ICH Q9 definition: “Quality risk management is a systematic process for the identification, assessment
ICH Q9 ‘Quality Risk Management’ - NIHS
www.nihs.go.jpICH Q9 ‘Quality Risk Management’ - an industry view Peter H. Gough, Eli Lilly and Company
Related documents
WHO Drug Information
apps.who.int155 WHO Drug Information Vol. 31, No. 2, 2017 Medicines regulation the NRA’s ability to identify manufacturing failures that may affect the safety profile
PHARMACEUTICAL INSPECTION CONVENTION …
www.it-asso.compi 041-1 (draft 2) 1 of 41 10 august 2016 pharmaceutical inspection convention pharmaceutical inspection co-operation scheme pi 041-1 (draft 2)
PIC Sの概要について - jpma.or.jp
www.jpma.or.jppic/sの概要について 日本製薬工業協会GMP事例研究会 2010年9月6/9日. 前田年秋. 製薬協gmp事例研2010.9.6/9
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comInspections involving GMP inspectors 4.09 Inspections involving GMP inspectors v1 Jul2006.doc Page 2 of 3 INTRODUCTION The Medicines Control Council (MCC) is a statutory body, appointed by the Minister of Health to register
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comGood Manufacturing Practice (GMP) describes a set of principles and procedures that when followed helps ensure that medicines and related substances are of high quality, safety and efficacy.
別紙（10） PIC/S GMP ガイドライン アネックス11 …
www.pref.kagawa.jp2/3 5. The software is a critical component of a computerised system. The user of such software should take all reasonable steps to ensure that it has been produced in
PIC/S GMPガイドに沿った 医薬品品質システム
www.toyama-kusuri.jp1 よりよい医薬品づくりを⽀援する「GMP Platform」 2015/03/17 GMP Seminar @ Toyama Pharmaceutical Association ® PIC/S GMPガイドに沿った 医薬品品質システム
Examples of critical and major observations from …
www.unicef.orgExamples of critical and major observations from GMP inspections of Manufacturing, QC and Contract Research Organisations Prequalification Programme: Priority …